Consensus
Chinese expert consensus on coronavirus disease 2019 vaccination for breast cancer patients
Translational Breast Cancer Research
2021;
2:
34
(31 October 2021)
Case Report
Case report: rare breast tumor—Schwannoma of the breast
Translational Breast Cancer Research
2021;
2:
33
(31 October 2021)
Case Report
More than 14 years’ progress free survival of neratinib monotherapy for human epidermal growth factor receptor 2 (HER2) positive advanced breast cancer: a case report
Translational Breast Cancer Research
2021;
2:
32
(31 October 2021)
Editorial Commentary
DESTINY-Breast01 Trial: trastuzumab deruxtecan in previously treated HER2 positive breast cancer
Translational Breast Cancer Research
2021;
2:
31
(31 October 2021)
Review Article
Current understandings and prospects of antibody-drug conjugates (ADCs) for the treatment of breast cancer: a narrative review
Translational Breast Cancer Research
2021;
2:
30
(31 October 2021)
Review Article
A narrative review of the current landscape and future perspectives of HER2-targeting antibody drug conjugates for advanced breast cancer
Translational Breast Cancer Research
2021;
2:
29
(31 October 2021)
Review Article
Sacituzumab govitecan in breast cancer
Translational Breast Cancer Research
2021;
2:
28
(31 October 2021)
Review Article
A narrative review of human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugates in the treatment of breast cancer
Translational Breast Cancer Research
2021;
2:
27
(31 October 2021)
